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To study therole ofinvariantNatural KillerT cell ( iNKT) cells in autoimmunethyroiditis,we derived twoiNKT cell linesfrom the
spleens of NOD· H2h4 mice, a strain that develops spontaneous autoimmunethyroiditis exacerbated by excess dietary iodine. The
two lines were CD1d-restricted and expressed CD4+,D X 5 +,a n dt h eV α4Jα281 gene segment, of the T-cell receptor α locus. Upon
stimulation with α-galactosyl-ceramide (α-GalCer), both lines rapidly produced IL-2, IL-4, IFN-γ, IL-10, and TNF-α. Strikingly,
a similar cytokine response was also induced by thyroglobulin, one of the most abundant protein in the thyroid gland and a
major autoantigen in human autoimmune thyroiditis. Transfer of the iNKT cell lines to syngeneic hosts enhanced autoimmune
thyroiditis. Intraperitoneal injections of α-GalCer in iodine primed mice also induced thyroid disease. This paper reports for the
ﬁrst time that iNKT cells respond to thyroglobulin and enhance autoimmune thyroiditis in iodine fed NOD·H2h4 mice.
1.Introduction
Autoimmune thyroiditis, also known as Hashimoto’s thy-
roiditis, ranks third in prevalence among the autoimmune
disorders in the United States [1], and is determined both
by genetic and environmental factors [2]. Some aspects
of Hashimoto’s thyroiditis can be duplicated using the
NOD·H2h4 mouse, a strain that spontaneously develops
thyroiditis at a low incidence. The incidence and severity
of thyroiditis can be exacerbated by supplementation of
sodium iodine (NaI) in the drinking water; almost 100%
of NOD·H2h4 mice drinking NaI-enriched water for 6 to
8 weeks develop moderate to severe thyroiditis [3, 4]. The
immunopathology of NOD·H2h4 thyroiditis is similar to
that of Hashimoto’s thyroiditis and is characterized by the
developmentof autoantibodies to thyroglobulin and chronic
inﬁltration ofthe thyroid gland by mononuclear cellssuch as
CD4+ T cells, CD8+ T cells, B cells, and macrophages [4–6].
Little is known about the role of regulatory immune cells
in the pathogenesis of autoimmune thyroiditis. Recent stud-
ies have shown that the iNKT cells are a unique population
of lymphocytes that downregulate several autoimmune dis-
eases, such as type 1 diabetes and experimental autoimmune
encephalomyelitis [7, 8]. Other contrasting studies, however,
have shown that iNKT cells may be pathogenic as shown in
CD8 T cell-induced NOD diabetes [9] and Con A-induced
hepatitis [10, 11]. Thus, since both disease improvement and
exacerbation have been shown, even within the same disease
model (NOD type I diabetes), the decisive role of iNKT cells
in autoimmune pathogenesis remains unclear.
Characteristically iNKT cells share receptors of both T
cells and NK cells (NK1.1 and/or DX5) [9, 12]a n dh a v ea n
alphachainoftheirT-cell receptorencodedbyinvariantgene
segments, Vα14 Jα18 in mice, and Vα24-JQ in humans [13–
15]. Two novel antigenic targets for iNKT cells, an exoge-
nous microbial cell antigen and an endogenous lysosomal2 Journal of Thyroid Research
glycosphingolipid isoglobotrihexosylceramide (iGb3), have
been discovered [16, 17]. Most iNKT cells promptly respond
to a synthetic ligand α-galactosyl-ceramide (α-GalCer) and
secreteavarietyofcytokinescharacteristicofbothTh1(IFN-
γ) and Th2 type (IL-4 and IL-13) responses [18, 19]. iNKT
cells interact with target hydrophobic antigens in the context
of CD1d, a nonpolymorphic, MHC class I-like molecule
usually expressed on conventional antigen presenting cells
(APC) [13, 20]. Several studies have documented extensive
heterogeneity and diversity in iNKT cell populations that
has led to their classiﬁcation into several subsets [18, 19].
A unique subset of iNKT cells has also been documented
that bears CD1d on their surface, lack NK1.1, and auto-
present α-GalCer in the absence of conventional APC
[21].
Previous studies have shown that adoptive transfer of
thyroglobulin-stimulated splenocytes induced autoimmune
thyroiditis in mice [22, 23]. However, the precise nature
of the speciﬁc immune cells that are responsible for trans-
ferring disease has not been well delineated. In this paper,
we describe two lines of iNKT cells that express surface
phenotype of CD4+DX5+, are CD1d-restricted, autopresent
thyroglobulin, and produceboth Th1 and Th2 cytokines.We
report that these lines of iNKT cells are nonprotective and
enhance thyroid autoimmunity in iodine-fed NOD·H2h4
mice.
2.Materialsand Methods
2.1. Mice. NOD·H2h4 mice were bred and maintained in the
Johns Hopkins University conventional animal facility. Both
male and female mice aged 10 to 12 weeks were used in the
studies. Test mice were fed 0.15% of NaI in their drinking
water and control mice received regular tap water.
2.2. Puriﬁcation of Mouse Thyroglobulin. Thyroglobulin was
puriﬁed as previously described [24]. Brieﬂy, mouse thyroid
glandswere dissected and homogenized in protease inhibitor
buﬀer. Debris was removed by centrifugation and the super-
natant was applied to a 1.6 × 88cm Sephacryl S300 column
(Sigma-Aldrich chemicals, St. Louis, MO) equilibrated with
PBS at 4◦C. The protein content of each column fraction was
determined by spectrophotometry (OD280) and ﬁnally by
BCAproteinassay kit(OD560)(PIERCE,Rockford,IL,USA).
Small aliquots of thyroglobulin were collected and frozen at
−20◦Cu n t i lu s e d .
2.3. Endotoxin Test. During the thyroglobulin puriﬁcation
process, precautions were taken to avoid any microbial or
endotoxin contamination. All thyroglobulin preparations
were analyzed using quantitative chromogenic QCL-1000
LAL-test kit bought from Bio-Whittaker, Walkersville, MD,
USA. Assay was performed according to the manufacturer’s
protocol. Brieﬂy, a series of twofold dilutions of endotoxin
standards (0.5EU/mL to 0.008EU/mL) was prepared. Py-
rogen-free, endotoxin-tested water (EU < 0.03, Invitrogen
Corporation, Carlsbad California) was used to prepare
samples and as a negative control. Serial dilutions of 50μLo f
either test or standard samples were prepared and incubated
for 10minutes at 37◦Cwith100μLofLimulusamoebolysate,
and then with 100μL of chromogenic substrate for 6 min-
utes. The reactionwas stoppedusing 100μLo fSt o ps o l uti o n .
The absorbance was read spectrophotometrically at 405nm
on ELISA plate reader (Dynatech Laboratories, USA). Thy-
roglobulin preparations with <0.125EU were considered en-
dotoxin-free and were used in all assays.
2.4. Thyroglobulin Antibody-Speciﬁc ELISA. Puriﬁed thyro-
globulin was coated onto 96 well Immunolon II plates
(Dynatech, USA) at a concentration of 2μg/mL in carbon-
ate/bicarbonate buﬀer (pH 9.6) and incubated overnight at
4◦C. The plates were washed 4 times with PBS-Tween 20
(0.05%) and blocked for 2hrs with 1% BSA-PBS. Plates
were then washed 3 times and incubated overnight with
mouse sera diluted 1:100 in PBS. Mouse thyroglobulin-
speciﬁc IgG subclasses were detected using appropriate
dilutions of secondary antibodies against IgG1 and IgG2b
(ICN Inc., Aurora, OH). Color was developed with p-
nitrophenylphosphate substrate (Sigma, St. Louis, MO).
Optical density (OD405) was read on MRX plate reader
(Dynatech Laboratories, USA).
2.5. Cell Preparation and Development of Cell Lines.
NOD·H2h4 mice were fed a low dose of sodium iodide
(0.05%)indrinking waterfor12 weeks. Spleenmononuclear
cells (MNCs) were isolated by density gradient centrifuga-
tion on Ficoll Paque (Pharmacia, Biotech, Sweden). Cells
were washed and cultured in 24 well plates at a density
of 106 cells/mL with complete RPMI 1640 supplemented
with 10% FBS, 20IU/mL penicillin, 20μg/mL streptomycin,
20mM/LL-glutamine,and100μMnonessential aminoacids
(all from GIBCO BRL, MD, USA). Bone marrow derived
dendritic cells were used as feeders. IL-2 (10ng/mL), IL-
4 (100U/mL), and GM-CSF (50ng/mL) (PharMingen, San
Diego, CA) were added to the cells every 3-4 days, and the
cells were stimulated with thyroglobulin every 14–18 days.
The cells proliferating in response to thyroglobulin were
selected for emergent cell lines and were then developed
in 96 well plates at a density of 3 × 10−2 cells/mL. Two
lines 1F1 and 2D11 were selected; line 1F1 was derived
twice and named as 1F1.1. Bone marrow derived dendritic
cells from the same mouse strain were used as feeder
layers. Control cell line was derived from an MHC II
matched OVA transgenic mouse. CD4+ cells were isolated
by magnetic separation using CD4 (L3T4) microbeads
(Miltenyi Biotech Inc. Auburn, California USA). Cells were
cultured in 6 well plates in supplemented complete medium
RPMI 1640and pulsed with 5μMc h i ck e nO V A 323–339peptide
(ISQAVHAAHAEINEAGR) (Fort Collins, CO USA) using
adherent APCs for 24 and 48 hours before adoptive
transfer.
2.6. Antibodies and Flow Cytometry. Surface expression of
iNKT cells was analyzed using ﬂuorescein isothiocyanate
(FITC)/peridinin chlorophyll protein (PerCP) conjugated
anti-CD4 (L3T4) and phycoerythrin-(PE-) coupled panJournal of Thyroid Research 3
NK anti-DX5 monoclonal antibodies (mAb). PE-coupled
mCD1d mAb (clone 1B1) (BD PharMingen, San Diego, CA,
USA) was used to analyze CD1d expression. Intracellu-
lar cytokine expression was measured using monoclonal
antibodies to mouse IL-2, IL-4, IFN-γ, IL-10, and TNF-α
coupled to PE (PharMingen, San Diego, CA). Three-color
staining was used to analyze cell surface markers, and in-
tracellular cytokines using standard protocol provided by
the manufacturer (BD PharMingen, San Diego, CA, USA).
Brieﬂy, developed iNKT cells were stimulated for 4 hours
with 45μg/mL of thyroglobulin in complete RPMI-1640 and
incubated for last 2 hours with Golgi stop (BD PharMingen,
San Diego, CA, USA). The cells were washed and stained for
30 minutes with cell surface markers followed by cell ﬁxation
and staining with intracellular cytokine markers. Flow cyto-
metric analysis was done on a FACSCalibur with Cellquest
software (Becton Dickinson, Heidelberg, Germany).
2.7. Expression of Vα14Jα281 in iNKT Cells. Mouse iNKT
cells express a TCRαβ that utilizes invariantly the Vα14
and Jα281 gene segments [15, 25]. Total RNA was ex-
tracted from each cell line (RNA easy Mini kit, QIA-
GEN, Valencia, CA) and reverse transcribed using the
primer 5
 -TGGCGTTGGTCTCTTT-GAAG-3
 ,w h i c hb i n d s
to the constant α region of the TCR. PCR ampliﬁca-
tion was then performed using the upstream primers 5
 -
TCCTGGTTGACCAAAAAGAC-3
 , which binds to the V
α14 region. The 443bp amplicon was separated on a 2%
agarose gel.
2.8. Proliferation Assay. A three-day proliferation assay was
performed to test the response of the iNKT cell lines
to thyroglobulin. Cells (2 × 104 cells/well) were cultured
for 72 hours in complete RPMI-1640 along with adher-
ent peritoneal macrophages as APCs and were stimulated
with 45μg/mL of thyroglobulin. To assess whether the
thyroglobulin-speciﬁc proliferation of iNKT cells depends
on CD1d engagement, proliferation assays were performed
with diﬀerent concentrations of puriﬁed mouse anti-CD1d
mAbforblocking(3.0–0.19μg/well, 0representing no mAb).
Cells were pulsed with 1μCi of [methyl-3H] thymidine
(Amersham, Pharmacia, NJ, USA) for the last 18 hours.
Proliferation was measured as incorporated [methyl-3H]
thymidineonamatrix 96directβ-scintillation counter(Wal-
lace, Germany). Data represents mean values of triplicate
wells after 4 minutes of counts on the beta-counter.
2.9. CD1d Tetramer Staining. Recombinant soluble CD1d
protein (gift from Dr. A. Bendelac) was incubated with
thyroglobulin (100ng) or with a 2μM solution of αGalCer
in 0.005% Tween 20; unbound protein was removed by
centrifugation dialysis in a Microcon YM-30 tube(Millipore,
Bedford, MA). Tetramers were formed by mixing thyroglob-
ulin or αGalCer-loaded monomers with PE-conjugated
streptavidin (at 5:1). Staining was done by incubating cells
on ice for 3h with tetramers at a concentration equivalent to
3–5μg/mLofCD1d1.FortheIL-2assay NKThybridomawas
similarly incubatedwithloadedCD1dandsecretoryIL-2was
measured in the supernatant.
2.10. Adoptive Transfer. iNKT cell lines were incubated
with thyroglobulin for 4 hrs at 37◦C in a humidiﬁed, 5%
CO2 incubator prior to transfer into 10-to-12 week-old
NOD·H2h4 mice. The cells were washed twice and resus-
pended in sterile PBS and injected intravenously (i.v.)
o nd a y s0a n d2a tac o n c e n t r a t i o no f5× 106 cells/
mouse. All mice were fed 0.15% NaI in their drinking
water 2 weeks prior to cell transfer. Mice were sacriﬁced
14 days postinjection; thyroids were dissected, and sera
collected for detection of autoantibodies to thyroglobulin.
Control groups received iodine water and injections of
sterile PBS i.v. at same time as test mice instead of cell
transfers. As a control cell line, OVA-speciﬁc CD4+ cells
were similarly transferred to iodine fed and age-matched
mice after stimulation with 5μMc h i c k e nO V A 323–339 pep-
tide (ISQAVHAAHAEINEAGR) (Fort Collins, CO USA)
using adherent APCs for 24 or 48 hours before adoptive
transfer.
2.11. Tracking of Transferred Cells. In order to track these
cells, iNKT cell lines which were derived from Thy1.2
NOD·H2h4 mice were adoptively transferred to iodine fed
Thy1.1 NOD·H2h4 mice at concentrations described above.
Cells were isolated from the thyroids after 14 days posttrans-
fers and were analyzed after enzymatic digestion by ﬂow
cytometry as previously described [26].
2.12. In Vivo α-GalCer Treatment and Iodine Priming of Mice.
NOD·H2h4 mice were used: experimental group n = 9a n d
controlgroupsofVehiclealonen = 5andiodine alonegroup
n = 7. Both males and females were included in the study.
Iodine was supplemented in their drinking water for two
weeks prior to α-GalCer injections. Two α-GalCer i.p. injec-
tions of 100μg/mouse on days 0 & 7 were given. Mice were
sacriﬁced on day 14.
2.13. Tissue and Serum Collection. Sera were collected prior
to iodine water treatment (day-14), on the day of adoptive
transfer of cells (day-0), and at day 14 posttransfer. Thyroids
were ﬁxed in 10% buﬀered formalin for 2 days, and submit-
ted for histological staining. Blood samples were incubated
at room temperature for 30 minutes; sera were collected after
centrifugation and stored at −80◦Cu n t i lu s e d .
2.14. Histology. Paraﬃn embedded sections of thyroids were
stained with hematoxylin and eosin and graded from 0 to 4
score based on the extent of mononuclear cell inﬁltration. A
grade of 0 was assigned for no lesions, 1 for <20% inﬁltra-
tion, 2 for 20–30%, 3 for >30–50%, 4 for >50% inﬁltration
of the thyroid.
2.15. Statistics. All comparisons ofnormally distributed data
were made using Student’s t-test; otherwise, Mann-Whitney4 Journal of Thyroid Research
U test was used.Test values were consideredtobe statistically
signiﬁcant from control values at P<. 05.
3.Results
3.1. Adoptive Transfer of Cell Lines Resulted in Autoimmune
Thyroiditis. T w oi N K Tc e l ll i n e sw e r ed e r i v e df r o mt h e
spleen cells of NOD·H2h4 mice stimulated with thyroglob-
ulin as described in methods. The possible role of these cell
lines in autoimmune thyroiditis was ﬁrst determined. Adop-
tivetransfers were performed withbothiNKTcell linesalong
with appropriate control cells such as OVA-speciﬁc CD4+
cells. Adoptive transfer experiments with both cell lines were
performed in iodine pretreated NOD·H2h4 mice. Mice were
sacriﬁced at day 14 following adoptive transfer, and results
were analyzed by (i) scoring thyroid histopathology, and (ii)
assessing thyroglobulin antibody by ELISA.
3.1.1. Thyroid Histology Showed Increased Cellular Inﬁl-
tration. Histological analysis of the cellular inﬁltrates of
mice receiving either cell line 1F1.1 or 2D11 cells revealed
moderate to dense cellular inﬁltration scoring from 2-3 (30–
50%) as well as intense follicular destruction as compared to
controls(Figures1(a)and 1(b)).Table 1 shows asummary of
results of disease frequency and severity of lesions developed
postadoptive transfer. Two control groups were used; one
group received iodine but no cell transfer and other did
not receive iodine but did receive equivalent number of
cells as the experimental groups. The control group that
received NaI in their drinking water for same time period
as the experimental group did not develop lesions in the
thyroid except for one mouse that developed a low level of
thyroiditis, probably due to the spontaneous phenotype of
themousemodel.Theadoptivetransferofline1F1.1resulted
in development of lesion scores from 1–3 in 8 of 12 mice.
Similarly line 2D11 resulted in lesion score of 1-2 in all 4 of
4m i c e( Table 1). Adoptive transfer of control OVA-speciﬁc
CD4+ cells showed no inﬁltration of the thyroid glands in
any of the mice (Table 1).
3.1.2. Thyroglobulin Antibody Levels Increased after Adoptive
Transfer of NKT Cells. Thyroglobulin-speciﬁc IgG1 and
IgG2b autoantibody subclasses were detected in the serum
of iNKT cell transfer recipients. Figure 2 shows results from
a representative adoptive transfer experiment from line
1F1.1. Signiﬁcantly increased levels of IgG1 (Figures 2(a)
and 2(b))( P<. 005) and IgG2b antibodies (Figures 2(c) and
2(d))( P = .02) to thyroglobulin were seen in almost all of
the mice receiving transfers in comparison to control mice
that received NaI alone (Figure 2). Since the production
of autoantibodies to thyroglobulin is indicative of thyroid
autoimmunity, these results suggested that all of the mice
receiving 1F1.1 cells in this particular experiment (n = 9)
developed enhanced response to thyroid autoantigens
culminating in thyroiditis. None of the mice that received
control OVA-speciﬁc CD4+ cells developed antibody to
thyroglobulin (data not shown). Since we now knew that
our cell lines could induce autoimmune thyroiditis in
NaI-treated NOD·H2h4 mice, we proceeded to characterize
these cells in detail.
3.2. Proliferative Response of Cell Lines to Mouse Thyroglobu-
lin. To show that the cell lines respond to thyroglobulin, we
performed an in vitro proliferation assay. The two cell lines,
1F1.1 and 2D11, were cultured for 72 hours at a cell con-
centration of 2 × 104/well on irradiated adherent peritoneal
macrophages with 45μg/mL of thyroglobulin. The same cell
lines were cultured with either ovalbumin or medium alone
as controls. Both cell lines showed a signiﬁcantly higher
proliferation in response to thyroglobulin (P = 7.9499E −
05); however, both lines also showed a weak response to
ovalbumin (Figure 3).Thus,we hypothesized thatiNKTcells
that are strongly responsive to ourthyroglobulinpreparation
enhance thyroid autoimmunity and contribute to disease.
3.3. Intracellular Cytokine Proﬁles of Cell Lines. iNKT cells
promptlyproducevariouscytokinesinresponse toα-GalCer.
To determine the intracytoplasmic cytokine expression, the
two lines were stimulated with thyroglobulin or α-GalCer.
Intracellular immunoﬂuorescent staining was performed at
various time points (2, 4, 8, 18, 24, and 48 hours), to deter-
mine the optimal time-point for the intracellular expression
of cytokines from the two lines (data not shown). After
performing the kinetics, we found that both lines expressed
intracellular cytokines within 4 hours of stimulation. The
expression of most cytokines disappeared after 10 hours.
Therefore, the 4-hour time point was used for further assays
and analyses. Interestingly, both cell lines displayed diﬀerent
patterns of intracellular cytokine production (Figures 4(a)
and 4(b)). Although both cell lines had high numbers of
IL-2-producing cells initially, but upon long-term culture
they lost this ability of IL-2 secretion. Line 1F1.1 showed a
polarization towards Th1 response. High number of IFN-γ
producing cells (approximately 72–82% with thyroglobulin
or α-GalCer resp.) and few IL-4 secreting cells (∼2%)
were recorded as shown in Figure 4(a). Line 2D11 showed
moderate numbers of both, IFN-γ (approximately 50–54%
with thyroglobulin or α-GalCer resp.) and IL-4 (approxi-
mately 28–44%with thyroglobulinor α-GalCerrespectively)
producing cells (Figure 4(b)). Thus, line 2D11 showed a
diﬀerent cytokine proﬁle as compared to line 1F1.1. IL-10
was found in signiﬁcant proportions of cells in both the
lines with 25–70% in 1F1.1 (with thyroglobulin or α-GalCer
resp.) and 38–42% in line 2D11 (with thyroglobulin or α-
GalCer, resp.). TNF-αwas found in almost all the cells of line
1F1.1butonly30–35%cellsofline 2D11.Thus, although the
variation in the numbers of cytokines secreting cells existed
among the two lines, the patternofcytokineswithin thelines
in response to either thyroglobulin or α-GalCer was similar.
Furthermore, upon repeated stimulation, the percentages
of cytokine producing cells of a particular line remained
constant (Figure 4 represents data from one representative
experiment).
3.4. Characterization of the Phenotype of Cell Lines. iNKT
cell lines that proliferated in response to thyroglobulin andJournal of Thyroid Research 5
(a) (b)
Figure 1: A representative ﬁgure of thyroid gland histology from a control mouse and a adaptively transferred with NKT cell line 1F1.1 is
shownafter hematoxylinand eosin(H& E) staining.(a) Normalthyroid histology showingfolliclessurrounded with thyrocytes. (b) Section
from thyroid gland after 14 days after adoptive transfer of iNKT cells line 1F1.1. Cellular inﬁltration and disruption of normal thyroid
histology was observed. The thyroid histology was assessed as a 5-point score as described in Table 1.
Table 1: Incidence and severity of thyroiditis after transfer of iNKT cell clones to NOD·H2h4 mice.
2-week administration of NaI Transferred iNKT cell clone Thyroiditis incidence Thyroiditis severity∗
0 123 4
Y e s — 1 / 1 2 1 1100 0
No 1F1.1 0/4 4 0 0 0 0
Yes 1F1.1 8/12 4 3 4 1 0
Y e s 2 D 1 1 4 / 4 0 130 0
Yes CD4+ (OVA speciﬁc) 0/4 4 0 0 0 0
Yes α-GalCer 5 / 9 4 130 1
Yes Vehicle 1 / 7 6 100 0
∗Thyroiditis severitywas scored as follows: 0 for no lesions, 1 for <20% inﬁltration, 2 for 20–30%, 3 for >30–50%, and 4 for >50% inﬁltration of the thyroid.
produced both Th1 and Th2 type cytokines were character-
ized for the expression of various cell phenotypic markers.
The cells were stained for the characteristic surface markers
associated with T cells (TCRαβ,C D 4 ,a n dC D 3 )a n dN K
cells (DX5, a pan-NK cell marker). Unstimulated cell lines
were also stained to determine the constitutive expression of
various surface markers. Both the cell lines in resting as well
as stimulated states expressed surface markers for TCRαβ+,
CD4+,C D 3 +,D X 5 +,a n dC D 6 9 + as shown in Table 2.I n
addition to common iNKT cell markers, our iNKT cells
also expressed CD1d on their surface. In order to detect
whether macrophages could be present in the cell cultures,
accounting for CD1d expression, macrophage/dendritic cell
markers (Mac1, CD80, and CD86) were also tested. None of
the cell lines showed detectable levels of such markers for
macrophages, dendritic cells, or other populations such as
CD8+ or B220+. However, coexpression of CD4+ and DX5+
was detected on 95–99% cells of both cell lines (Table 2,
Figure 5). It is not surprising that NK1.1, a common marker
for NK cells, was not observed on the cell lines since NK cells
from parental NOD mice do not display this allelic marker
[12].
Although these results suggested that the lines are in-
deed a subset of iNKT cells, further conﬁrmation was re-
quired. A classical characteristic of most iNKT cells is their
restricted usage of the invariant chain TCRαβ encoded
by Vα14Jα281 gene rearrangement [14, 15]. Importantly,
both cell lines expressed Vα14Jα281 as shown by RT-PCR
(Figure 6). In contrast, a CD4+ NK1.1−/DX5− T cell clone,
used as a negative control, did not show any such expression
(Figure 6). These results conﬁrm that the cell lines produced
and stimulated by our thyroglobulin preparation derived
from NOD·H2h4 mice are a subset of iNKT cells. Hence,
the mixed Th1/Th2 cytokine proﬁle from these cells as
shown above is not surprising, since autoimmune thyroiditis
shows both Th1 and Th2 cytokines with disease pathology
[5, 27], and iNKT cells are also known to release large
amounts of both types of cytokines following four hours of
stimulation.
3.5. CD1d-Restriction of iNKT Cell Lines. Most iNKT cell
subsets recognize lipids or hydrophobic peptide antigens in
the context of CD1d, that is usually expressed on antigen
presenting cells [28]. We found that our iNKT cell lines6 Journal of Thyroid Research
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Figure 2: Adoptive transfer of iNKT line 1F1.1 in 8–10-week-old syngeneic mice induced antibodies to thyroglobulin. Mice in panels (a)
and (c) received pretreatment of iodine and received iNKT cells. Both, IgG1 and IgG2b (a and c) antibody titers in the treatment groups
(posttransfer day 14) were signiﬁcantly higher as compared to the control group of mice (b and d). Shown IgG1 with P<. 005 and IgG2b
with P = .02. Control group mice on panels (b) and (d) received iodine pretreatment but no cells. No signiﬁcant increase in the antibody
titer to thyroglobulin was seen in control groups.
expressed CD1d and proliferated in response to thyroglob-
ulin in the absence of conventional APCs (Figure 7). The
proliferationassay resultssuggestedthatCD1dbearing iNKT
cells are capable of auto-presenting antigen in absence of
conventional APCs as described earlier by Hameg et al. [21].
To test the dependence of the cell lines on CD1d for stim-
ulation by thyroglobulin, we blocked CD1d using a CD1d
monoclonal antibody (mAb). We found that thyroglobulin-
speciﬁc proliferation was completely abrogated in a dose-
dependent fashion with CD1d mAb treatment, whereasJournal of Thyroid Research 7
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Figure 3: In vitro response of iNKT cells to thyroglobulin. A 72-hour proliferation assay was performed in response to 45μg/mL of
thyroglobulin. [3H]-thymidine incorporation was used as an indicator of stimulation response. Both cell lines showed a signiﬁcantly higher
proliferation in response to thyroglobulin. A few cells also proliferated in response to Ovalbumin (Ova). Results are expressed as mean
counts/4 minutes of [3H]-thyrmidine uptake. (Representative of 3 independent experiments).
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Figure 4: Cytokine response of two iNKT cell lines. Cells were stimulated with thyroglobulin or α-GalCer four hours prior to staining.
Intracellular cytokine expressions were then detected by ﬂow cytometry as described in methods. Both lines showed a burst of cytokines
after 4 hours of stimulation. (a) Line 1F1.1 showing high levels IFN-γ, but low levels of IL-4. (b) Line 2D11 showing elevated levels of both
IFN-γ and IL-4. Data represents percent of total iNKT cells expressing intracellular cytokines.
unblocked cells eﬃciently proliferated in response to thy-
roglobulin stimulation (Figure 7).
To conﬁrm the CD1d speciﬁcity of iNKT cell lines, we
used tetramers for CD1d. FACS staining using α-GalCer-
CD1d-speciﬁc tetramers conﬁrmed that the lines are iNKT
cells. Clones cells gated on CD4+DX5+ were found to be
>8 8 %p o s i t i v ef o rC D 1 dt e t r a m e rs t a i n i n g( F i g u r e s8(a) and
8(b)). These results verify that our cell lines are functionally
CD1d-restricted and recognized α-GalCer like typical iNKT
cell clones.
3.6. In Vivo Treatment of α-GalCer Enhanced Thyroiditis in
NOD·H2h4 Mice. Mice were given two α-GalCer injections
i.p. after a short period (two weeks) of iodine treatment. As
shown in Table 1, 55% of mice that received α-GalCer in-
jections developed inﬁltration of the thyroid gland after 14
days. Approximately 22% of mice (2 of 9) also developed
autoantibody to thyroglobulin (data not shown). From
the control group, only 14% of mice (1 of 7) developed
low-grade thyroid histology, but none of them developed
detectable levels of thyroid autoantibody (Table 1).
3.7. Tracking iNKT Cells in the Thyroids. Since iNKT cells
contribute to autoimmune thyroid autoimmunity in trans-
fer experiments, it is important to determine the site of
action of their adoptive transfer. To address this question8 Journal of Thyroid Research
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Figure 6: Expression of Vα14 Jα281 on iNKT cells. Mouse iNKT
cells express a TCRαβ that utilizes invariant Vα14 and Jα281 gene
segments. RT-PCR using speciﬁc primers showed that lines 1F1,
1F1.1 subderived line of 1F1 and 2D11, all expressed Vα14Jα281
region, whereas a standard CD4+ T cell clone was negative for this
expression.The443bp ampliconwasseparatedona2%agarosegel.
we performed adoptive transfer experiments using iNKT
cell lines from NOD·H2h4 mice with Thy1.2 expression
into NOD·H2h4 mice expressing Thy1.1. The cells were
transferred ina similar manner asdescribed earlier. Thyroids
were collected for disease assessment 14 days following cell
transfers. Single-cellsuspensionswerepreparedandanalyzed
for detection of Thy1.2 iNKT cells. No inﬁltrating Thy1.2
expressing iNKT cells were detected by ﬂow cytometry
analysis (data not shown). However, we could detect CD45+
inﬁltrating lymphocytes on day 14, indicating disease pro-
gression. We interpretthese resultstoshow that(i)these cells
were short lived and/or (ii) inﬂuenced disease development
indirectly through their cytokines most probably in the local
lymph nodes but not intrusive in the thyroid gland itself.
4.Discussion
In this paper, we report that adoptive transfer of iNKT
cell lines enhanced spontaneous thyroiditis in susceptible
recipient mice. The characterization of the cell lines was
established initially by detecting the surface phenotype of
both CD4+ and DX5+ (a pan-NK cell marker), and then by
the expression of invariant TCR α-chain: Vα14Jα281. Both
cell lines were found to coexpress CD4+ and DX5+ on their
surface. NK1.1, a marker commonly used to identify NK
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Figure 7: Demonstration of CD1d dependence of iNKT cells.
Proliferationofline 1F1.1in response to thyroglobulin was assessed
after blocking CD1d. Diﬀerent concentrations of mouse CD1d
mAb were used starting from 0.0–3.0μg/well. Concentration 0
represents no blocking. Proliferation in response to thyroglobulin
was abrogated after CD1d blocking showing that iNKT cells
recognized thyroglobulin in a CD1d-dependent manner. [3H]
thymidine incorporation was measured as an indicator of prolifer-
ative response. Data represents mean CPM of triplicate wells from
each concentration.
cells, was not detected on either of cell lines. This is not
surprising since NOD mice, along with many other mouse
strains donotexpresstheNK1.1antigen[12].Theexpression
of DX5 protein has been shown to be positive for all mouse
strains studied and hence has been widely used as a marker
to identify NK cells [9, 13]. The overall phenotypic analysis
ofthecell linesindicatedthat thevast majority ofcellswithin
the culture, at least 95–99% of the cells, expressed the iNKT
cell phenotype.
In order to gain a better understanding of the functional
characteristics of the iNKT cell lines, we examined their
response to thyroglobulin or ovalbumin stimulation. In
addition to proliferation in response to thyroglobulin, both
lines responded weakly to ovalbumin. CD1d is known
to have a much deeper groove than the classical MHCJournal of Thyroid Research 9
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Figure 8: CD1d tetramer stainingto showCD1d-restriction ofiNKT cells. Flowcytometry wasused to determinethe percentage of tetramer
positive cells from the homogeneous population of CD4+DX5+ iNKT cells. (a) Surface phenotype showing CD4+DX5+ of line 2D11. (b)
Tetramer positive cells represented under M2 gate showing 88.8 % CD1d tetramer positive cells.
molecules,which bindswith ahigh aﬃnity toglycolipidsand
hydrophobic peptides[28]. It is known that the hydrophobic
end of ovalbumin also binds to the CD1d groove with high
aﬃnity. Perhaps thyroglobulin, having many hydrophobic
areas, issimilarly presentedbyCD1dtoiNKTcells[29].Even
though subsets of iNKT cells recognize antigens presented
by CD1d, little is known about the role of exogenous
hydrophobicpeptideantigens,suchasthyroglobulinorother
natural ligands, in the processing, presentation, selection,
and development of iNKT cells. Our proliferation data
suggest that thyroglobulin, or a derived peptide, may be a
candidate ligand for CD1d-dependentiNKT cell stimulation
in iodine-fed NOD·H2h4 mice. Iodine modiﬁcation may still
further contribute to the hydrophobic nature and stability of
the thyroid autoantigen [30, 31].
The presence of CD1d on the surface of the iNKT
cell lines suggests that these cells may be able to present
thyroglobulin in an autocrine or paracrine manner. Because
CD1d blocking inhibited the stimulation of these cells, it
conﬁrmed their CD1d restriction. However, it is not yet
clear how thyroglobulin is processed. A study on char-
acterization and sequence of human thyroglobulin (hTg)
recognized the disease-inducing eﬀect of a 40-amino acid
(F40D) peptide from hTg. The pathogenic F40D peptide of
human thyroglobulin was found to be highly hydrophobic
in nature and located at the end of the second third of
the thyroglobulin molecule. Injection of this peptide into
thyroiditis-susceptible CBA/J mice strain induced severe
autoimmune thyroiditis [32]. It is a possibility that iNKT
cells may recognize hydrophobic peptide F40D or a similar
hydrophobicpeptide,leadingtopathogenicityinNOD·H2h4
similar to CBA/J. Alternatively iNKT cells may autopresent
antigen by a mechanism similar to a subset of CD8+
T cells that autopresents α-GalCer [21]. Recent studies
demonstrate that human CD1d restricted T cells via αβTCR,
under certain inﬂammatory and autoimmune conditions,
are capable of recognizing molecular structures of nonlipid
small peptide molecules [33]. It appears that processing
o fa n t i g e nm a yt a k ep l a c eb ym o r et h a no n ew a yi nv i v o
depending on the nature of antigen resulting in generation
of pathogenic immune responses against more than one
epitope of thyroglobulin. A recent study has shown that a
plasminogen-like protein that is present in the apical region
of thyroid epithelial cells naturally degrades thyroglobulin
in order to maintain the concentration of thyroglobulin
in the lumen of thyrocytes [34]. We speculate that during
this process of degradation small hydrophobic antigenic
fragments are formed that could be presented to iNKT
cells in context of CD1d. Therefore, studying the factors
promoting pathogenic epitopes during the processing and
presentationofthyroglobulinbyCD1d-bearingAPCsshould
help to learn more about the recognition of thyroglobulin by
iNKT cells and their role in disease pathogenesis.
The unique capacity of iNKT cells to promptly release
cytokines upon antigenic stimulation is thought to be
the basis of their regulatory functions during the eﬀector
phase of the immune response, especially in regulation of
autoimmune disorders [8, 35]. iNKTcells may downregulate
disease either by secreting cytokines that are protective [7]o r
by recruiting tolerogenic dendritic cells [36]. FACS analysis
of the intracellular cytokine proﬁles of our iNKT cell lines
revealed a diverse cytokine proﬁle representing both Th1
and Th2 types after 4 hours of thyroglobulin stimulation
(Figure 4) as supported by previous studies from iNKT cells
stimulated in vitro [37, 38]o rin vivo [39]. The diverse
cytokine proﬁles of iNKT cells are known to be related to
the nature of the antigen that stimulates them [38, 40]. For
example,α-GalCerhasbeenusedtodeterminethefunctional
signiﬁcance of iNKT cell populations in the protection
or prevention of autoimmune diseases such as type 1
diabetes and experimental autoimmune encephalomyelitis
where protection of mice was associated with biased Th2
response [35, 40].
Stimulation of our iNKT cell lines with thyroglobulin
or α- G a l C e rr e v e a l e do n l ys l i g h t l yd i ﬀerent cytokine proﬁles
between the two lines. After stimulation with either thy-
roglobulin or α-GalCer, both cell lines rapidly produced
certain key cytokines such as IL-2, IL-4, IFN-γ, IL-10, and10 Journal of Thyroid Research
Table 2: Surface phenotype of two lines of iNKT cells. Both lines expressed markers for T and NK cells.
Surface markers 1F1.1 2D11 CD4 (control)
T-cell markers
TCRαβ ++ +
CD3 + + +
CD4 + + +
CD8 −− −
CD69 + + +
NK cell markers
DX5 + + −
NK1.1 −− −
Ly6 + + −
APC markers
CD1d + + −
Mac1 −− −
CD80 −− −
CD86 −− −
TNF-α. Although the iNKT cell lines produced slightly
diﬀerent cytokine levels, both were capable of enhancing
disease in genetically susceptible mice. Since iNKT cells
were stimulated only with the thyroglobulin preparation,
as presented by CD1d molecules, diﬀerent epitopes of
thyroglobulin could possibly be a ligand of iNKT cells.
We thus suspect that in NOD·H2h4 mice and possibly in
susceptible humans, autoimmune thyroiditis is enhanced
indirectly by the cytokine products of iNKT cells in response
to thyroglobulin stimulation.
Although Th1-type CD4+ T cells are considered to be
the predominant contributors to the initiation and persist-
ence of autoimmune thyroiditis [5, 41], our study using
thyroglobulin-stimulated iNKT cell lines that express IL-
2, IFN-γ, IL-10, and TNF-α implicate a role for iNKT
cells in the enhancement of autoimmune thyroiditis. A
signiﬁcant increase in serum levels of IgG1 and IgG2b
antibodies to thyroglobulin 14 days after adoptive transfer
of iNKT cell lines further suggests a key role of iNKT cells
in the enhancement of thyroidal autoimmunity. The precise
mechanisms involved in the enhancement of autoimmune
thyroiditis by these iNKT cell lines are still unclear. Work
by other investigators has clearly demonstrated that NKT
cells promote autoimmune disease under certain conditions
[10, 11, 42, 43]. It has beensuggested that thestage of disease
in which NKT cells are introduced into the experimental
system play a major role in the outcome of disease. For
example, if given early, prior to the start of disease the
result is protection, but if given after initiation of disease,
the result is disease enhancement [44]. In our experimental
model of iodine-induced thyroiditis in the NOD·H2h4
mouse, transfer of the 1F1.1 iNKT cell line promoted disease
only in iodine-primed mice, further suggesting that the
role of these cells is enhancement rather than initiation of
disease.
In summary, iNKT cell lines were derived from spleens
of NOD·H2h4 mice by repeated stimulation with a mouse
thyroglobulin preparation. These cell lines have all the
molecular and functional earmarks of iNK T cells. When
these lines were transferred into iodine-primed NOD·H2h4
recipients, thyroid autoimmunity was enhanced. In this
model system of iodine-induced thyroiditis, these iNKTcells
may be producing large quantities of Th1 cytokines, such
as IFNg or TNFα, that dominate a more protective role of
the Th2 cytokine response. These experiments lend further
caution about NKT cell therapy for autoimmune diseases,
as what may be protective in one could lead to disease
enhancement in another.
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